Cargando…
Using Synthetic ApoC-II Peptides and nAngptl4 Fragments to Measure Lipoprotein Lipase Activity in Radiometric and Fluorescent Assays
Lipoprotein lipase (LPL) plays a crucial role in preventing dyslipidemia by hydrolyzing triglycerides (TGs) in packaged lipoproteins. Since hypertriglyceridemia (HTG) is a major risk factor for cardiovascular disease (CVD), the leading cause of death worldwide, methods that accurately quantify the h...
Autores principales: | Oldham, Dean, Wang, Hong, Mullen, Juliet, Lietzke, Emma, Sprenger, Kayla, Reigan, Philip, Eckel, Robert H., Bruce, Kimberley D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329559/ https://www.ncbi.nlm.nih.gov/pubmed/35911520 http://dx.doi.org/10.3389/fcvm.2022.926631 |
Ejemplares similares
-
Primary tumor–derived systemic nANGPTL4 inhibits metastasis
por: Hübers, Corinne, et al.
Publicado: (2022) -
Inverse effects of APOC2 and ANGPTL4 on the conformational dynamics of lid-anchoring structures in lipoprotein lipase
por: Kumari, Anni, et al.
Publicado: (2023) -
Genetic Variants of Lipoprotein Lipase and Regulatory Factors Associated with Alzheimer’s Disease Risk
por: D. Bruce, Kimberley, et al.
Publicado: (2020) -
New Therapeutic Approaches to the Treatment of Dyslipidemia 1: ApoC-III and ANGPTL3
por: Kim, Ji Yoon, et al.
Publicado: (2023) -
Short hydrocarbon stapled ApoC2-mimetic peptides activate lipoprotein lipase and lower plasma triglycerides in mice
por: Sviridov, Denis, et al.
Publicado: (2023)